title: Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts.
abstract: Cells of the osteoblastic lineage play a major role in the regulation of osteoclastic bone resorption. Recent studies have demonstrated production of chemokines by osteoblastic cells. Although these phagocyte-stimulating and proinflammatory cytokines act as chemoattractants and activators for other members of the hemopoietic lineage, their actions on osteoclasts have not been characterized. We found that macrophage inflammatory protein-1 alpha (MIP-1 alpha) and IL-8 inhibited bone resorption by rat osteoclasts, primarily through reduction in the proportion of osteoclasts resorbing bone, a pattern of inhibition previously observed in response to macrophage CSF (M-CSF). MIP-2, RANTES, MIP-1 beta, and monocyte chemotactic protein-1 were without effect on resorption. MIP-1 alpha and IL-8, but not the other chemokines, also stimulated osteoclastic motility and increased the osteoclast spread area in a dose-dependent manner, over the same concentration range as that which inhibited bone resorption. In addition, MIP-1 alpha induced osteoclast orientation in a gradient of the chemokine, and stimulated osteoclast migration. We detected no effect of chemokines on osteoclast formation or survival. Our data suggest that chemokines can promote osteoclast orientation and migration, processes that might be involved in chemotaxis; it seems appropriate that resorptive functions should be suppressed during migration. Because chemokines are proinflammatory, their actions on osteoclasts might represent mechanisms by which bone resorption is modulated by the inflammatory process when this occurs in bone. However, given that chemokines are increasingly recognized to be multifunctional and that they are produced by cells of the osteoblastic lineage, they may also be components of the physiologic regulation of bone resorption.
authors.affiliation: Department of Histopathology, St. George's Hospital Medical School, London, United Kingdom.
authors.forename: K
authors.initials: K
authors.lastname: Fuller
authors.forename: J M
authors.initials: JM
authors.lastname: Owens
authors.forename: T J
authors.initials: TJ
authors.lastname: Chambers
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells; D001862:Bone Resorption / Q000276:immunology*; D002465:Cell Movement / Q000276:immunology*; D002478:Cells, Cultured; D018932:Chemokine CCL2; D054407:Chemokine CCL4; D054426:Chemokine CXCL2; D002630:Chemotactic Factors / Q000502:physiology; D016207:Cytokines / Q000502:physiology*; D016209:Interleukin-8 / Q000502:physiology*; D019402:Macrophage Inflammatory Proteins; D015846:Monokines / Q000502:physiology*; D010010:Osteoclasts / Q000276:immunology*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D018932:Chemokine CCL2; D054407:Chemokine CCL4; D054426:Chemokine CXCL2; D002630:Chemotactic Factors; D016207:Cytokines; D016209:Interleukin-8; D019402:Macrophage Inflammatory Proteins; D015846:Monokines